Gracell Biotechnologies Completes $85 Million Series B for Imm...
SUZHOU and SHANGHAI, China, Feb. 26, 2019/PRNewswire-AsiaNet/-- -- Gracell addresses the issues of complex manufacture and high cost of cellular gene therapeutics Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its $85 million series B funding today. The financing was led by Tema...
Authors: LATEST ASIANET NEWS RELEASES